Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03769467
Title Tabelecleucel in Combination With Pembrolizumab in Subjects With EBV+ Nasopharyngeal Carcinoma (ATA129-NPC-202)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Atara Biotherapeutics
Age Groups: child | adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Stanford Hospital and Clinics Palo Alto California 94305 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Atlantic Health System / Morristown Medical Center Morristown New Jersey 07962 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Pennsylvania (Adults and Pediatrics) Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from for the field